---
title: "BiomX Inc. (PHGE.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PHGE.US.md"
symbol: "PHGE.US"
name: "BiomX Inc."
industry: "Biotechnology"
datetime: "2026-05-20T16:07:13.478Z"
locales:
  - [en](https://longbridge.com/en/quote/PHGE.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PHGE.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PHGE.US.md)
---

# BiomX Inc. (PHGE.US)

## Company Overview

BiomX Inc., a clinical-stage biopharmaceutical company, develops phage-based therapies using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases. The company’s phage-based therapies include fixed cocktail therapy, which involves developing a single product containing a fixed number of selected phages to cover a range of bacterial strains; and personalized therapy, which involves developing a large library of phages from which single optimal phages are personally matched to treat specific patients. It develops BX011, a fixed multi-phage cocktail, which is in Phase 2a trial for the treatment of diabetic foot infections; and BX211, a phage therapy, which is in Phase 2 trial for the treatment of diabetic foot osteomyelitis. BiomX Inc.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.biomx.com](https://www.biomx.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.07 | 74 | - | - | - |
| PB | -0.12 | 461 | 27.88 | 19.77 | 1.97 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-16T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Hold | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.59 |
| Highest Target | 304.00 |
| Lowest Target | 304.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/PHGE.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/PHGE.US/norm.md)
- [Related News](https://longbridge.com/en/quote/PHGE.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/PHGE.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**